GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » WIN-Partners Co Ltd (TSE:3183) » Definitions » Cyclically Adjusted PS Ratio

WIN-Partners Co (TSE:3183) Cyclically Adjusted PS Ratio : 0.52 (As of Jun. 10, 2024)


View and export this data going back to 2013. Start your Free Trial

What is WIN-Partners Co Cyclically Adjusted PS Ratio?

As of today (2024-06-10), WIN-Partners Co's current share price is 円1195.00. WIN-Partners Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was 円2,291.52. WIN-Partners Co's Cyclically Adjusted PS Ratio for today is 0.52.

The historical rank and industry rank for WIN-Partners Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

TSE:3183' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.11   Med: 0.47   Max: 0.57
Current: 0.52

During the past years, WIN-Partners Co's highest Cyclically Adjusted PS Ratio was 0.57. The lowest was 0.11. And the median was 0.47.

TSE:3183's Cyclically Adjusted PS Ratio is ranked worse than
58.46% of 65 companies
in the Medical Distribution industry
Industry Median: 0.38 vs TSE:3183: 0.52

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

WIN-Partners Co's adjusted revenue per share data for the three months ended in Dec. 2023 was 円690.175. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is 円2,291.52 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


WIN-Partners Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for WIN-Partners Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WIN-Partners Co Cyclically Adjusted PS Ratio Chart

WIN-Partners Co Annual Data
Trend Mar12 Mar13 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.13 0.51 0.47

WIN-Partners Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.51 0.47 0.47 0.48 0.52

Competitive Comparison of WIN-Partners Co's Cyclically Adjusted PS Ratio

For the Medical Distribution subindustry, WIN-Partners Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


WIN-Partners Co's Cyclically Adjusted PS Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, WIN-Partners Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where WIN-Partners Co's Cyclically Adjusted PS Ratio falls into.



WIN-Partners Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

WIN-Partners Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=1195.00/2291.52
=0.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

WIN-Partners Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, WIN-Partners Co's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=690.175/106.8000*106.8000
=690.175

Current CPI (Dec. 2023) = 106.8000.

WIN-Partners Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201112 347.586 94.300 393.660
201203 357.261 95.100 401.214
201206 316.906 94.400 358.533
201209 319.668 94.400 361.658
201212 378.521 94.100 429.607
201303 374.422 94.200 424.504
201309 0.000 95.400 0.000
201512 0.000 98.100 0.000
201603 502.075 97.900 547.718
201606 477.013 98.100 519.317
201609 488.350 98.000 532.202
201612 505.068 98.400 548.184
201703 541.566 98.100 589.595
201706 507.570 98.500 550.340
201709 528.851 98.800 571.673
201712 587.786 99.400 631.545
201803 564.468 99.200 607.714
201806 552.988 99.200 595.354
201809 556.932 99.900 595.399
201812 654.066 99.700 700.644
201903 666.549 99.700 714.016
201906 594.842 99.800 636.564
201909 559.704 100.100 597.167
201912 538.077 100.500 571.807
202003 555.456 100.300 591.453
202006 447.394 99.900 478.295
202009 523.882 99.900 560.066
202012 577.790 99.300 621.430
202103 614.928 99.900 657.401
202106 537.714 99.500 577.164
202109 547.144 100.100 583.766
202112 616.947 100.100 658.241
202203 613.530 101.100 648.121
202206 589.165 101.800 618.102
202209 593.698 103.100 615.004
202212 624.042 104.100 640.228
202303 686.215 104.400 701.990
202306 611.650 105.200 620.953
202309 625.120 106.200 628.652
202312 690.175 106.800 690.175

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


WIN-Partners Co  (TSE:3183) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


WIN-Partners Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of WIN-Partners Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


WIN-Partners Co (TSE:3183) Business Description

Traded in Other Exchanges
N/A
Address
2-2-1 Kyobashi, Chuoku, 21st Floor, Kyobashi Edogrand, Tokyo, JPN, 104-0031
WIN-Partners Co Ltd is engaged in the healthcare sector. The company provides medical devices to Japan's medical institutions. Its products offerings are Cardiovascular device, Insulin Pump, X-ray Angio System, Carotid Artery Stent, Stent Graft, among others.

WIN-Partners Co (TSE:3183) Headlines

No Headlines